Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Cynamon

Showing results (91-100 of 95) with videos related to

Pageof 10
Sort By:
You have reached the last page of results.This site can display upto 95 results.
Antimicrobial Agents and Chemotherapy|December 24, 2014
A novel inhibitor of gyrase B is a potent drug candidate for treatment of tuberculosis and nontuberculosis mycobacterial infectionsChristopher P Locher, Steven M Jones, Brian L Hanzelka, et al.
Bioorganic & Medicinal Chemistry Letters|August 6, 2017
2-N-Arylthiazole inhibitors of Mycobacterium tuberculosisMichael P Clark, Tiansheng Wang, Emanuele Perola, et al.
Journal of Medicinal Chemistry|February 2, 1996
Identification of a novel oxazolidinone (U-100480) with potent antimycobacterial activityM R Barbachyn, D K Hutchinson, S J Brickner, et al.
American Journal of Respiratory and Critical Care Medicine|November 15, 2018
Advancing Translational Science for Pulmonary Nontuberculous Mycobacterial Infections. A Road Map for ResearchShelby Daniel-Wayman, Getahun Abate, Daniel L Barber, et al.
ACS Infectious Diseases|January 27, 2023
Synthesis and Testing of Analogs of the Tuberculosis Drug Candidate SQ109 against Bacteria and Protozoa: Identification of Lead Compounds against <i>Mycobacterium abscessus</i> and Malaria ParasitesMarianna Stampolaki, Satish R Malwal, Nadine Alvarez-Cabrera, et al.
Pageof 10

Showing results (91-100 of 95) with videos related to

Sort By:
Pageof 10
You have reached the last page of results.This site can display upto 95 results.
Antimicrobial Agents and Chemotherapy|December 24, 2014
A novel inhibitor of gyrase B is a potent drug candidate for treatment of tuberculosis and nontuberculosis mycobacterial infectionsChristopher P Locher, Steven M Jones, Brian L Hanzelka, et al.
Bioorganic & Medicinal Chemistry Letters|August 6, 2017
2-N-Arylthiazole inhibitors of Mycobacterium tuberculosisMichael P Clark, Tiansheng Wang, Emanuele Perola, et al.
Journal of Medicinal Chemistry|February 2, 1996
Identification of a novel oxazolidinone (U-100480) with potent antimycobacterial activityM R Barbachyn, D K Hutchinson, S J Brickner, et al.
American Journal of Respiratory and Critical Care Medicine|November 15, 2018
Advancing Translational Science for Pulmonary Nontuberculous Mycobacterial Infections. A Road Map for ResearchShelby Daniel-Wayman, Getahun Abate, Daniel L Barber, et al.
ACS Infectious Diseases|January 27, 2023
Synthesis and Testing of Analogs of the Tuberculosis Drug Candidate SQ109 against Bacteria and Protozoa: Identification of Lead Compounds against <i>Mycobacterium abscessus</i> and Malaria ParasitesMarianna Stampolaki, Satish R Malwal, Nadine Alvarez-Cabrera, et al.
Pageof 10